WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine…